Name
As of 11/22/2024Price
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
Vitals
YTD Return
13.6%
1 yr return
24.7%
3 Yr Avg Return
-0.7%
5 Yr Avg Return
6.9%
Net Assets
$1.13 B
Holdings in Top 10
21.7%
52 WEEK LOW AND HIGH
Expenses
OPERATING FEES
Expense Ratio 0.98%
SALES FEES
Front Load N/A
Deferred Load N/A
TRADING FEES
Turnover 28.00%
Redemption Fee N/A
Min Investment
Standard (Taxable)
$0
IRA
N/A
Fund Classification
Fund Type
Open End Mutual Fund
Name
As of 11/22/2024Price
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
HBMCX - Profile
Distributions
- YTD Total Return 13.6%
- 3 Yr Annualized Total Return -0.7%
- 5 Yr Annualized Total Return 6.9%
- Capital Gain Distribution Frequency Semi-Annually
- Net Income Ratio 0.37%
- Dividend Yield 0.0%
- Dividend Distribution Frequency Annual
Fund Details
-
Legal NameHARTFORD MIDCAP HLS FUND
-
Fund Family NameHARTFORD FUNDS
-
Inception DateOct 04, 2002
-
Shares OutstandingN/A
-
Share ClassI
-
CurrencyUSD
-
Domiciled CountryUS
-
ManagerMark Whitaker
Fund Description
HBMCX - Performance
Return Ranking - Trailing
Period | HBMCX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | 13.6% | 0.5% | 130.5% | 83.21% |
1 Yr | 24.7% | 12.0% | 130.4% | 82.82% |
3 Yr | -0.7%* | -20.3% | 60.0% | 64.55% |
5 Yr | 6.9%* | -1.4% | 103.7% | 94.06% |
10 Yr | 8.7%* | 2.2% | 25.6% | 88.71% |
* Annualized
Return Ranking - Calendar
Period | HBMCX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | 5.7% | -27.7% | 68.0% | 95.79% |
2022 | -36.8% | -85.6% | 52.8% | 79.96% |
2021 | -8.2% | -74.9% | 238.3% | 71.83% |
2020 | 13.2% | -44.1% | 2474.5% | 85.45% |
2019 | 12.3% | -50.2% | 44.0% | 92.18% |
Total Return Ranking - Trailing
Period | HBMCX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | 13.6% | 0.5% | 130.5% | 83.21% |
1 Yr | 24.7% | 12.0% | 130.4% | 82.82% |
3 Yr | -0.7%* | -20.3% | 60.0% | 64.55% |
5 Yr | 6.9%* | -1.4% | 103.7% | 94.06% |
10 Yr | 8.7%* | 2.2% | 25.6% | 88.71% |
* Annualized
Total Return Ranking - Calendar
Period | HBMCX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | 14.5% | -26.1% | 68.0% | 83.52% |
2022 | -24.5% | -67.0% | 56.8% | 28.90% |
2021 | 9.6% | -23.5% | 342.2% | 70.24% |
2020 | 24.8% | 2.6% | 2549.1% | 81.97% |
2019 | 32.5% | 14.6% | 44.8% | 57.51% |
NAV & Total Return History
HBMCX - Holdings
Concentration Analysis
HBMCX | Category Low | Category High | HBMCX % Rank | |
---|---|---|---|---|
Net Assets | 1.13 B | 2.73 M | 100 B | 51.15% |
Number of Holdings | 99 | 24 | 3581 | 30.34% |
Net Assets in Top 10 | 205 M | 670 K | 11.3 B | 56.30% |
Weighting of Top 10 | 21.69% | 4.5% | 97.8% | 78.24% |
Top 10 Holdings
- Datadog Inc 2.79%
- CyberArk Software Ltd 2.34%
- Targa Resources Corp 2.34%
- DraftKings Inc 2.26%
- Monolithic Power Systems Inc 2.26%
- PTC Inc 2.02%
- WEX Inc 2.01%
- Dexcom Inc 1.98%
- NVR Inc 1.88%
- Fair Isaac Corp 1.82%
Asset Allocation
Weighting | Return Low | Return High | HBMCX % Rank | |
---|---|---|---|---|
Stocks | 99.93% | 58.72% | 103.99% | 10.31% |
Cash | 0.99% | 0.00% | 28.07% | 64.31% |
Other | 0.02% | -0.04% | 14.45% | 22.14% |
Preferred Stocks | 0.00% | 0.00% | 5.73% | 89.69% |
Convertible Bonds | 0.00% | 0.00% | 0.40% | 89.69% |
Bonds | 0.00% | 0.00% | 2.73% | 89.89% |
Stock Sector Breakdown
Weighting | Return Low | Return High | HBMCX % Rank | |
---|---|---|---|---|
Technology | 25.04% | 0.04% | 62.17% | 73.85% |
Healthcare | 18.04% | 0.00% | 37.06% | 47.33% |
Industrials | 16.03% | 0.00% | 38.23% | 33.78% |
Financial Services | 13.32% | 0.00% | 43.01% | 18.51% |
Consumer Cyclical | 10.86% | 0.00% | 57.41% | 77.48% |
Basic Materials | 3.99% | 0.00% | 17.25% | 24.81% |
Real Estate | 3.41% | 0.00% | 19.28% | 34.16% |
Communication Services | 2.81% | 0.00% | 18.33% | 52.86% |
Utilities | 2.80% | 0.00% | 12.94% | 7.25% |
Energy | 2.38% | 0.00% | 62.10% | 40.84% |
Consumer Defense | 1.32% | 0.00% | 16.40% | 68.32% |
Stock Geographic Breakdown
Weighting | Return Low | Return High | HBMCX % Rank | |
---|---|---|---|---|
US | 99.93% | 46.79% | 103.99% | 8.40% |
Non US | 0.00% | 0.00% | 34.12% | 92.37% |
HBMCX - Expenses
Operational Fees
HBMCX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Expense Ratio | 0.98% | 0.02% | 17.54% | 58.59% |
Management Fee | 0.70% | 0.00% | 1.50% | 46.27% |
12b-1 Fee | 0.25% | 0.00% | 1.00% | 62.20% |
Administrative Fee | N/A | 0.00% | 0.40% | 3.11% |
Sales Fees
HBMCX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Front Load | N/A | 3.00% | 5.75% | N/A |
Deferred Load | N/A | 1.00% | 5.00% | N/A |
Trading Fees
HBMCX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Max Redemption Fee | N/A | 1.00% | 2.00% | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
HBMCX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Turnover | 28.00% | 0.00% | 250.31% | 35.52% |
HBMCX - Distributions
Dividend Yield Analysis
HBMCX | Category Low | Category High | HBMCX % Rank | |
---|---|---|---|---|
Dividend Yield | 0.00% | 0.00% | 33.43% | 93.32% |
Dividend Distribution Analysis
HBMCX | Category Low | Category High | Category Mod | |
---|---|---|---|---|
Dividend Distribution Frequency | Annual | Annual | Annual | Annual |
Net Income Ratio Analysis
HBMCX | Category Low | Category High | HBMCX % Rank | |
---|---|---|---|---|
Net Income Ratio | 0.37% | -2.24% | 2.75% | 8.72% |
Capital Gain Distribution Analysis
HBMCX | Category Low | Category High | Capital Mode | |
---|---|---|---|---|
Capital Gain Distribution Frequency | Semi-Annually | Annually | Annually | Annually |
Distributions History
Date | Amount | Type |
---|---|---|
Aug 23, 2024 | $0.157 | CapitalGainShortTerm |
Aug 23, 2024 | $0.520 | CapitalGainLongTerm |
Dec 22, 2023 | $0.128 | CapitalGainShortTerm |
Aug 25, 2023 | $1.842 | CapitalGainLongTerm |
Aug 26, 2022 | $0.185 | OrdinaryDividend |
Aug 26, 2022 | $4.781 | CapitalGainLongTerm |
Dec 22, 2021 | $0.679 | CapitalGainShortTerm |
Aug 27, 2021 | $0.407 | CapitalGainShortTerm |
Aug 27, 2021 | $6.299 | CapitalGainLongTerm |
Dec 21, 2020 | $0.605 | CapitalGainLongTerm |
Aug 27, 2020 | $0.083 | CapitalGainShortTerm |
Aug 27, 2020 | $2.951 | CapitalGainLongTerm |
Aug 27, 2019 | $0.026 | CapitalGainShortTerm |
Aug 27, 2019 | $6.110 | CapitalGainLongTerm |
Dec 21, 2018 | $0.207 | CapitalGainShortTerm |
Aug 23, 2018 | $0.128 | CapitalGainShortTerm |
Aug 23, 2018 | $3.643 | CapitalGainLongTerm |
Dec 20, 2017 | $0.593 | CapitalGainShortTerm |
Aug 24, 2017 | $1.258 | CapitalGainLongTerm |
Aug 25, 2016 | $0.010 | ExtraDividend |
Aug 25, 2016 | $3.618 | CapitalGainLongTerm |
Dec 22, 2015 | $0.013 | CapitalGainShortTerm |
Aug 19, 2015 | $0.032 | ExtraDividend |
Aug 19, 2015 | $0.245 | CapitalGainShortTerm |
Aug 19, 2015 | $4.195 | CapitalGainLongTerm |
Dec 22, 2014 | $0.299 | CapitalGainShortTerm |
Aug 27, 2014 | $0.300 | CapitalGainShortTerm |
Aug 27, 2014 | $4.210 | CapitalGainLongTerm |
Dec 20, 2013 | $0.281 | CapitalGainShortTerm |
Aug 13, 2013 | $0.006 | ExtraDividend |
Aug 13, 2013 | $1.060 | CapitalGainLongTerm |
Dec 27, 2012 | $0.157 | OrdinaryDividend |
Dec 28, 2011 | $0.049 | OrdinaryDividend |
Aug 26, 2010 | $0.014 | OrdinaryDividend |
Dec 17, 2009 | $0.047 | OrdinaryDividend |
Aug 27, 2009 | $0.007 | OrdinaryDividend |
Dec 16, 2008 | $0.049 | OrdinaryDividend |
Jun 23, 2008 | $0.013 | OrdinaryDividend |
Jun 23, 2008 | $0.450 | CapitalGainShortTerm |
Jun 23, 2008 | $0.647 | CapitalGainLongTerm |
Dec 17, 2007 | $0.063 | OrdinaryDividend |
Dec 17, 2007 | $1.177 | CapitalGainShortTerm |
Dec 17, 2007 | $2.686 | CapitalGainLongTerm |
Jun 19, 2007 | $0.007 | OrdinaryDividend |
Jun 19, 2007 | $0.108 | CapitalGainShortTerm |
Jun 19, 2007 | $0.575 | CapitalGainLongTerm |
Dec 13, 2006 | $0.255 | OrdinaryDividend |
Dec 13, 2006 | $0.162 | CapitalGainShortTerm |
Dec 13, 2006 | $3.738 | CapitalGainLongTerm |
Jun 22, 2006 | $0.216 | CapitalGainShortTerm |
Jun 22, 2006 | $0.583 | CapitalGainLongTerm |
Dec 19, 2005 | $0.550 | CapitalGainShortTerm |
Dec 19, 2005 | $3.419 | CapitalGainLongTerm |
Dec 19, 2005 | $0.021 | OrdinaryDividend |
Jun 22, 2005 | $0.510 | CapitalGainLongTerm |
Dec 15, 2004 | $0.030 | OrdinaryDividend |
HBMCX - Fund Manager Analysis
Managers
Mark Whitaker
Start Date
Tenure
Tenure Rank
Mar 01, 2010
12.26
12.3%
Mark A. Whitaker, CFA, Senior Managing Director and Equity Portfolio Manager, is involved in portfolio management for Funds. Mark is an equity portfolio manager on Wellington Management's Mid Cap Opportunities Team, which manages accounts for a globally diverse group of individual, institutional, and mutual fund clients. Prior to joining the firm in 2004, Mark was an equity research analyst at Morgan Stanley, covering packaging and containers and electrical equipment (2000 — 2002). Before that, Mark was a cash management consultant at Ernst & Young (1999 — 2000). Mark received his MBA from Stanford University (2004) and his BS in business administration from the University of Kansas, Lawrence (1999). He holds the Chartered Financial Analyst designation.
Philip Ruedi
Start Date
Tenure
Tenure Rank
May 01, 2010
12.09
12.1%
Philip W. Ruedi, CFA, Senior Managing Director and Equity Portfolio Manager, is Portfolio Manager for the Hartford MidCap Funds. Phil is an equity portfolio manager on Wellington Management's Mid Cap Opportunities Team, which manages accounts for a globally diverse group of individual, institutional, and mutual fund clients. Prior to joining the firm in 2004, Phil was an equity research analyst at T. Rowe Price, covering a variety of industries, including waste management, staffing, IT services, food and drug retailing, parcel delivery, and other business and consumer services (1998 — 2004). While at T. Rowe Price, Phil was a member of the Investment Advisory Committee of the T. Rowe Price Mid Cap Growth Fund and was chosen to Institutional Investor magazine's "Best of the Buyside" in 2002. Before that, he was an analyst in John Nuveen's Health Care Mergers and Acquisitions Group (1993 — 1997). Phil received his MBA with a concentration in finance, with high honors, from the University of Chicago (1998) and his BBA in finance and accounting, with high distinction, from the University of Michigan (1993). He also holds the Chartered Financial Analyst designation.
Tenure Analysis
Category Low | Category High | Category Average | Category Mode |
---|---|---|---|
0.04 | 36.3 | 9.4 | 11.76 |